UPDATE 2-AstraZeneca respiratory business gets boost from 3-drug inhaler results
August 28, 2019 at 09:17 AM EDT
* Fasenra gets U.S. FDA orphan drug status (Adds details on Breztri data)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.